Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05954546
What this trial is testing

Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings

Who this might be right for
Metastatic Melanoma
Pfizer 275
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Large-scale testing (Phase 3)Study completedNCT00472459
What this trial is testing

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Who this might be right for
Actinic KeratosisWartsBasal Cell Carcinoma+2 more
Galderma R&D 82
Testing effectiveness (Phase 2)Study completedNCT03207347
What this trial is testing

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Who this might be right for
MesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more
University of Florida 37
Large-scale testing (Phase 3)WithdrawnNCT01861938
What this trial is testing

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Who this might be right for
High Risk HLA-A2+ MelanomaMetastatic Disease
Hadassah Medical Organization
Testing effectiveness (Phase 2)Study completedNCT00755976
What this trial is testing

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Cancer Trials Ireland 32
Not applicableStudy completedNCT06705608
What this trial is testing

Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study

Who this might be right for
Multiple SclerosisSkin CancerSkin Cancer Melanoma+3 more
University of British Columbia 4,000
Testing effectiveness (Phase 2)Study completedNCT00404235
What this trial is testing

Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
Alliance for Clinical Trials in Oncology 76
Early research (Phase 1)Ended earlyNCT06336148
What this trial is testing

A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Actym Therapeutics, Inc. 10
Not applicableStudy completedNCT01886235
What this trial is testing

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT02272855
What this trial is testing

Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Takara Bio Inc. 46
Testing effectiveness (Phase 2)Study completedNCT00911443
What this trial is testing

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
sigma-tau i.f.r. S.p.A. 488
Testing effectiveness (Phase 2)Study completedNCT00056134
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University Hospital Erlangen 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT02656706
What this trial is testing

Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma

Who this might be right for
Melanoma
Brown University 22
Testing effectiveness (Phase 2)Study completedNCT00960752
What this trial is testing

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 47
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Large-scale testing (Phase 3)Study completedNCT01597908
What this trial is testing

Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 704
Large-scale testing (Phase 3)UnknownNCT01729663
What this trial is testing

Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients

Who this might be right for
Cutaneous Melanoma
Laboratorio Pablo Cassara S.R.L. 108
Not applicableStudy completedNCT05087485
What this trial is testing

Integrated Basic Science Within the Instructional Design of Pattern Recognition Training

Who this might be right for
MelanomaSkin Cancer
Herlev Hospital 87
Not applicableWithdrawnNCT03989050
What this trial is testing

Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
MelanomaNon Small Cell Lung Cancer
University of Cologne
Next Page